Susan Ritger Crowell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Susan Ritger Crowell has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Richard A. Corley
Pacific Northwest National Laboratory, Richland, WA 99352, USA
3 shared publications - Arun K. Sharma
Department of Molecular and Precision Medicine, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA 17033, USA
2 shared publications David E. Williams
‡Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331
2 shared publicationsJolen J. Soelberg
‡Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331
2 shared publications- Aaron T. Wright
Baylor University
1 shared publication D.E. Williams
Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States
1 shared publication
Latest Publications
- 1 July 2014
- Published by Elsevier in Toxicology Letters
- Vol. 228 (1) , 48-55
In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes
- 1 July 2014
- Published by Elsevier in Toxicology Letters
- Vol. 228 (1) , 48-55
In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes
- Open Access
- 6 June 2013
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 135 (1) , 48-62
Impact of Pregnancy on the Pharmacokinetics of Dibenzo[def,p]chrysene in Mice
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants generated during combustion. Dibenzo[def,p]chrysene (DBC) is a high molecular weight PAH classified as a 2B carcinogen by the International Agency for Research on Cancer. DBC crosses the placenta in exposed mice, causing carcinogenicity in offspring. We present pharmacokinetic data of DBC in pregnant and nonpregnant mice. Pregnant (gestational day 17) and nonpregnant female B6129SF1/J mice were exposed to 15mg/kg DBC by oral gavage. Subgroups of mice were sacrificed up to 48h postdosing, and blood, excreta, and tissues were analyzed for DBC and its major diol and tetrol metabolites. Elevated maximum concentrations and areas under the curve of DBC and its metabolites were observed in blood and tissues of pregnant animals compared with naïve mice. Using a physiologically based pharmacokinetic (PBPK) model, we found observed differences in pharmacokinetics could not be attributed solely to changes in tissue volumes and blood flows that occur during pregnancy. Measurement of enzyme activity in naïve and pregnant mice by activity-based protein profiling indicated a 2- to 10-fold reduction in activities of many of the enzymes relevant to PAH metabolism. Incorporating this reduction into the PBPK model improved model predictions. Concentrations of DBC in fetuses were one to two orders of magnitude below maternal blood concentrations, whereas metabolite concentrations closely resembled those observed in maternal blood.
- 6 June 2013
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 135 (1) , 48-62
Open AccessImpact of Pregnancy on the Pharmacokinetics of Dibenzo[def,p]chrysene in Mice
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants generated during combustion. Dibenzo[def,p]chrysene (DBC) is a high molecular weight PAH classified as a 2B carcinogen by the International Agency for Research on Cancer. DBC crosses the placenta in exposed mice, causing carcinogenicity in offspring. We present pharmacokinetic data of DBC in pregnant and nonpregnant mice. Pregnant (gestational day 17) and nonpregnant female B6129SF1/J mice were exposed to 15mg/kg DBC by oral gavage. Subgroups of mice were sacrificed up to 48h postdosing, and blood, excreta, and tissues were analyzed for DBC and its major diol and tetrol metabolites. Elevated maximum concentrations and areas under the curve of DBC and its metabolites were observed in blood and tissues of pregnant animals compared with naïve mice. Using a physiologically based pharmacokinetic (PBPK) model, we found observed differences in pharmacokinetics could not be attributed solely to changes in tissue volumes and blood flows that occur during pregnancy. Measurement of enzyme activity in naïve and pregnant mice by activity-based protein profiling indicated a 2- to 10-fold reduction in activities of many of the enzymes relevant to PAH metabolism. Incorporating this reduction into the PBPK model improved model predictions. Concentrations of DBC in fetuses were one to two orders of magnitude below maternal blood concentrations, whereas metabolite concentrations closely resembled those observed in maternal blood.
- 1 December 2011
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 257 (3) , 365-376
Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents
- 1 December 2011
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 257 (3) , 365-376
Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents